Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Non-Diabetic Chronic Kidney Disease
NCT07315139Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pentoxifylline in chronic kidney disease (CKD) (2 arms), sponsored by Ain Shams University. Primary endpoint: Levels of inflammatory marker at 3 months. Started Feb 2023; status: completed.
02
Drugs
pentoxifylline
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07315139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07315139.